Purchases and Sales Made in Q2 2024 in Uro Gen Pharma Ltd. (URGN)
This table provides information about the institutional ownership of Uro Gen Pharma Ltd. (URGN) during Q2 2024. The information is specifically focused on institutions that hold shares of UroGen Pharma Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Dec 26, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-49.3K- 72.46% |
$627K - $947K
|
18.7K
$289K
|
|
|
Aug 14, 2024
Q2 2024
|
Laurion Capital Management LP
New York, NY |
SELL
|
- |
-90K- 35.91% |
$1.14M - $1.73M
|
161K
$2.47M
|
|
|
Jul 22, 2024
Q2 2024
|
Harel Insurance Investments & Financial Services Ltd.
|
SELL
|
- |
-210K- 31.17% |
$2.67M - $4.03M
|
464K
$7.14M
|
|
|
Aug 14, 2024
Q2 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-256K- 95.9% |
$3.26M - $4.92M
|
10.9K
$169K
|